EFFECT OF SYNTHETIC HUMAN CHOLECYSTOKININ-33 ON PANCREATIC BLOOD-FLOW IN DOGS

被引:0
|
作者
DOI, R
HOSOTANI, R
INOUE, K
KOGIRE, M
SUMI, S
FUJII, N
YAJIMA, H
RAYFORD, PL
TOBE, T
机构
[1] First Department of Surgery, Kyoto University, Kyoto
[2] Kyoto University, Kyoto
[3] Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR
关键词
Cholecystokinin; L-364; 718; Pancreatic blood flow; Pancreatic secretion; Receptor antagonist;
D O I
10.1097/00006676-199009000-00019
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We have examined the effect of synthetic human cholecystokinin (CCK-33 and CCK-8) on pancreatic blood flow and protein output in anesthetized dogs. Human CCK-33 and CCK-8 increased pancreatic blood flow and protein output in a dose-related manner. There were no significant differences in increasing pancreatic blood flow between human CCK-33 and CCK-8, and increases in blood flow were closely related to the increase of the pancreatic enzyme secretion. L-364,718 (20 nmol/kg) caused a potent inhibition of CCK-stimulated pancreatic blood flow as well as protein output. The degree of inhibition by L-364,718 was dependent on the amount of CCK infused. This study demonstrates that increasing effect on pancreatic blood flow may be one of the biological actions of CCK mediated via CCK receptor. The CCK-33, one of longer molecular forms of CCK, is an important biological stimulator of pancreatic blood flow as well as of exocrine pancreatic secretion. © 1990 Raven Press, Ltd., New York.
引用
收藏
页码:615 / 620
页数:6
相关论文
共 50 条
  • [1] EFFECT OF SYNTHETIC HUMAN CHOLECYSTOKININ-33 ON EXOCRINE PANCREAS
    DOI, R
    INOUE, K
    KOGIRE, M
    SUMI, S
    YUN, M
    FUTAKI, S
    FUJII, N
    YAJIMA, H
    TOBE, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 150 (03) : 1251 - 1255
  • [2] THE SATIETY EFFECT OF CHOLECYSTOKININ-33
    MELVILLE, LD
    SMITH, GP
    GIBBS, J
    APPETITE, 1992, 19 (02) : 201 - 201
  • [3] NEUROTENSIN - EFFECT OF PANCREATIC-SECRETION AND RELEASE OF GASTRIN, PANCREATIC-POLYPEPTIDE, AND CHOLECYSTOKININ-33 IN DOGS
    NEWMAN, J
    TOWNSEND, CM
    GREELEY, GH
    THOMPSON, JC
    SURGICAL FORUM, 1983, 34 : 213 - 216
  • [4] TOTAL SYNTHESIS OF HUMAN CHOLECYSTOKININ-33
    FUJII, N
    FUTAKI, S
    MORIMOTO, H
    INOUE, K
    DOI, R
    TOBE, T
    YAJIMA, H
    JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1988, (04) : 324 - 325
  • [5] The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33
    Rehfeld, JF
    Sun, G
    Christensen, T
    Hillingso, JG
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01): : 251 - 258
  • [6] EFFECT OF HEPATIC TRANSIT ON ACTIONS OF CHOLECYSTOKININ-8 AND CHOLECYSTOKININ-33 ON THE EXOCRINE PANCREAS IN DOGS
    SAKAMOTO, T
    FUJIMURA, M
    ZHU, XG
    THOMPSON, JC
    SURGICAL FORUM, 1983, 34 : 211 - 213
  • [7] RELATIVE BIOACTIVITIES OF CHOLECYSTOKININ-8 AND CHOLECYSTOKININ-33 ON RAT PANCREATIC ACINI
    LIDDLE, RA
    ELASHOFF, J
    REEVE, JR
    PEPTIDES, 1986, 7 (05) : 723 - 727
  • [8] PHARMACOLOGICAL ACTIVITIES OF SYNTHETIC HUMAN CHOLECYSTOKININ-33 OF WHICH TYROSINE WAS SULFATED BY ARYLSULFOTRANSFERASE
    HAGIWARA, M
    OHUCHI, E
    HONGO, K
    OKI, M
    NAKANO, M
    AMEMIYA, M
    MORIKAWA, T
    KOBASHI, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1990, 38 (05) : 1369 - 1372
  • [9] EFFECTS OF SYNTHETIC HUMAN PANCREASTATIN ON PANCREATIC-SECRETION AND BLOOD-FLOW IN RATS AND DOGS
    DOI, R
    INOUE, K
    HOSOTANI, R
    HIGASHIDE, S
    TAKAORI, K
    FUNAKOSHI, S
    YAJIMA, H
    RAYFORD, PL
    TOBE, T
    PEPTIDES, 1991, 12 (03) : 499 - 502
  • [10] PORCINE CHOLECYSTOKININ-33 AMINO-TERMINAL SPECIFIC RADIOIMMUNOASSAY DEVELOPED WITH SYNTHETIC PORCINE CHOLECYSTOKININ-33 AMINO-TERMINAL HEPTACOSAPEPTIDE
    IGUCHI, K
    YANAIHARA, C
    KUBOTA, M
    IWANAGA, T
    FUJITA, T
    MATSUO, Y
    MIYOSHI, A
    YANAIHARA, N
    BIOMEDICAL RESEARCH-TOKYO, 1983, 4 : 189 - 196